Article: H.C. Wainwright Starts Ekso Bionics (EKSO) at Buy

Article - Media

H.C. Wainwright Starts Ekso Bionics (EKSO) at Buy

StreetInsider.com, 28 October 2019

H.C. Wainwright analyst Swayampakula Ramakanth initiates coverage on Ekso Bionics (NASDAQ: EKSO) with a Buy rating and a price target of $1.20.

Read full article.

 

Comment: This appears to be a stellar example of a life-saving vital technology company being destroyed by collusion between a placement agent and naked short sellers.

RELATED: